Combined action of type I and type III interferon restricts initial replication of severe acute respiratory syndrome coronavirus in the lung but fails to inhibit systemic virus spread

STAT1-deficient mice are more susceptible to infection with severe acute respiratory syndrome coronavirus (SARS-CoV) than type I interferon (IFN) receptor-deficient mice. We used mice lacking functional receptors for both type I and type III IFN (double knockout, dKO) to evaluate the possibility tha...

Full description

Saved in:
Bibliographic Details
Published inJournal of general virology Vol. 93; no. Pt 12; pp. 2601 - 2605
Main Authors MAHLAKOIV, Tanel, RITZ, Daniel, MORDSTEIN, Markus, DEDIEGO, Marta L, ENJUANES, Luis, MÜLLER, Marcel A, DROSTEN, Christian, STAEHELI, Peter
Format Journal Article
LanguageEnglish
Published Reading Society for General Microbiology 01.12.2012
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:STAT1-deficient mice are more susceptible to infection with severe acute respiratory syndrome coronavirus (SARS-CoV) than type I interferon (IFN) receptor-deficient mice. We used mice lacking functional receptors for both type I and type III IFN (double knockout, dKO) to evaluate the possibility that type III IFN plays a decisive role in SARS-CoV protection. We found that viral peak titres in lungs of dKO and STAT1-deficient mice were similar, but significantly higher than in wild-type mice. The kinetics of viral clearance from the lung were also comparable in dKO and STAT1-deficient mice. Surprisingly, however, infected dKO mice remained healthy, whereas infected STAT1-deficient mice developed liver pathology and eventually succumbed to neurological disease. Our data suggest that the failure of STAT1-deficient mice to control initial SARS-CoV replication efficiently in the lung is due to impaired type I and type III IFN signalling, whereas the failure to control subsequent systemic viral spread is due to unrelated defects in STAT1-deficient mice.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0022-1317
1465-2099
1465-2099
DOI:10.1099/vir.0.046284-0